Press Releases

Customers can now shop thousands of Natural Grocers products online for on-demand delivery from all 174 stores nationwideLAKEWOOD, Colo., Sept. 3, 2026 /PRNewswire/ -- Natural Grocers®, the nation's largest family-operated natural and organic grocery retailer, announces a new partnership with DoorDash, making grocery delivery available from all 174 Natural Grocers locations nationwide. Natural Grocers® now offers on-demand delivery nationwide through DoorDash.Customers can now shop thousands of Natural Grocers products online, including 100% USDA-certified organic produce, responsibly sourced meats and seafood, dietary suppleme

LAUSANNE, Switzerland, Sept. 3, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE:ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York, NY, on Friday, September 11, 2026, at 9:10 a.m. ET. A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com. A replay of the webcast will be available for approximately 30 days.About ADC TherapeuticsADC Therapeutics (NYSE:ADCT) is a commercial-stage global leader and pioneer in the

Provides Full-Year Fiscal 2027 Guidance Targeting $500 Million Cost Savings by Fiscal 2030 Resetting Dividend to Accelerate Debt Reduction Fourth Quarter: Net Sales decreased 8% to $2.1 billion and decreased 1% on an organic basis. Earnings Before Interest and Taxes (EBIT) decreased to $4 million; Adjusted EBIT decreased 25% to $242 million, including an estimated 8% impact from the extra week in the prior year period. Earnings Per Share (EPS) decreased to $(0.23); Adjusted EPS decreased 37% to $0.39, including an estimated $0.06 per share, or 7%, impact from the extra week in the prior year period. Full Year: Net Sales decreased 5% to $9.7 billion and decreased 2% on an or

Sip smart with our clear prebiotic soda — a balanced refresher for when you're on the goSALT LAKE CITY, Sept. 3, 2026 /PRNewswire/ -- Rise Wellness announced the launch of Protein Pop Balance, the newest addition to its Protein Pop lineup of clear, ready-to-drink protein beverages. A sparkling, clear prebiotic soda, Protein Pop Balance is available now online at proteinpop.com and on Amazon, with distribution expanding to Target and other major retailers in mid-September. The beverage launches in four flavors — Lime Slush, Tropical Pineapple, Watermelon Lime, and Fruit Punch — giving consumers a lighter, gut-friendly option that rounds out the brand's growing portfolio of functional, protein

MELBOURNE, Australia and SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer, will participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 on Friday, September 11, 2026 at 10:20 a.m. ET in the United States. A link to the live and archived webcast may be accessed on Alterity Therapeutics website under the Investors section: Events and Presentations. About Alterity Therapeutics Limited Alterity Therapeutics is a clinic

BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions. "Our vision is that healthcare works better when technology brings the ecosystem together," said Dan Zamansky, Chief Product and Technology Officer at Amwell. "We're building the integrated infrastructure that connects patients, provi

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today announced that management will participate in fireside chats at the following investor conferences: 21st Annual Wells Fargo Healthcare Conference on Thursday, September 10, 2026 Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026 A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time. About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that bring

- Bank Targets Adding at Least US$3 Billion in US SRP in Fiscal 2027 and Accelerated Growth in Canada -- Bank Expects to Drive Further Efficiency Through Broader Implementation of AI -All amounts are unaudited and in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Our third quarter 2026 ("Q3 2026") unaudited Interim Consolidated Financial Statements for the period ended July 31, 2026 and Management's Discussion and Analysis ("MD&A"), are available online at www.versabank.com/investor-relations, SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov/edgar. Supplementary Fi

London, Ontario--(Newsfile Corp. - September 3, 2026) - VersaBank (TSX:VBNK) (NASDAQ:VBNK) (the "Bank") today announced that cash dividends in the amount of CAD $0.025 per Common Share of the Bank have been declared for the quarter ending October 31, 2026, payable as of October 31, 2026, to shareholders of record at the close of business on October 9, 2026.The dividends to which this notice relates are eligible dividends for tax purposes.About VersaBank VersaBank is a North American bank with a difference. Federally chartered in both Canada and the U.S., VersaBank has a branchless, digital, business-to-business model based on its proprietary state-of-the-art technology that enables it to pr

NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ:IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 255,000 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan.  The options have a per share exercise price of $0.8799, representing the closing price of Invivyd’s common stock on the grant date. Each option vests over four years, with 25% of the shares subject to such option vesting on the

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ:BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. BioHarvest expects its shares to begin trading on the TASE on September 8, 2026.Dr Zaki Rakib, CEO of BioHarvest Sciences, commented, "BioHarvest is entering an exciting new phase of growth, built on the strength of our Botanical Synthesis platform and the commercial opportunities it is creating.

Reverse Stock Split Previously Approved by Shareholders; Intended to Support Compliance with Nasdaq's $1.00 Minimum Bid Price RequirementExpected to Become Effective and Trade on Split-Adjusted Basis at the Market Open on September 8, 2026PRINCETON, N.J., Sept. 3, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it will effect a one-for-twenty (1:20) reverse stock split (the "Reverse Stock Split") of its common stock, par value $0.001 per share (the "Common Stock"). The Reverse Stock Split is expected to become effective on Septemb

INDIANAPOLIS, Sept. 3, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) ("Calumet") announced today that it plans to attend the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15 and will hold one-on-one investor meetings throughout the day. About CalumetCalumet, Inc. (NASDAQ:CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in Indianapolis, Indiana and operates twelve facilities throughout North America. View original content to

Formally pivoted to building specialized AI agents; Ambre and MIA now in market as the first two products.Total revenue reached US$13.9 million, up 38.8% quarter-over-quarter; US$7.4 million classified as agentic, supporting 79.5% gross margin and positive operating income and Adjusted EBITDA.SINGAPORE, Sept. 3, 2026 /PRNewswire/ -- Amber International Holding Limited (NASDAQ:AMBR) ("Amber International", "we," "us," or the "Company") today announced Second Quarter 2026 Unaudited Financial Results. Management CommentaryMichael Wu, Chairman and Chief Executive Officer of Amber International, commented:"The second quarter was a s

—New Data Explore Efficacy and Safety of BRINSUPRI ® (brensocatib) in Patients With Non-Cystic Fibrosis Bronchiectasis (NCFB) and History of Nontuberculous Mycobacterial (NTM) Lung Disease——New Research Examines Treprostinil Palmitil Inhalation Powder (TPIP) via COMPERA 2.0 Risk Assessment in Pulmonary Arterial Hypertension (PAH)—BRIDGEWATER, N.J., Sept. 3, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that five abstracts highlighting data from its respiratory portfolio have been accepted for presentation

LOS ANGELES, Sept. 3, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced a paper in the Journal of Molecular Biology, a peer-reviewed journal. The publication, titled "Insights into Genome Ejection by a Therapeutic phiKMV-like Bacteriophage," presents an integrative structural atlas of Ar-KM, a phiKMV-like bacteriophage that targets Pseudomonas aeruginosa ("

Summary Fiscal third quarter 2026 revenue was $1.67 billion, up 37% year-over-year Fiscal third quarter 2026 adjusted Earnings Per Share (EPS) was $2.11, an increase of 215% compared to fiscal third quarter 2025 Providing revenue guidance for fiscal fourth quarter 2026 of $1.75 billion plus or minus $50 million Raising revenue guidance for fiscal year 2026 to $6.42 billion plus or minus $50 million, a 35% increase year-over-year at the midpoint Ciena® Corporation (NYSE:CIEN) today announced financial results for its fiscal third quarter ended August 1, 2026. "Today’s outstanding financial performance demonstrates Ciena’s leadership in providing industry-leading, high-speed

Record H1 2026 retail sales of 30,423 cars supported by 39% growth of retail network year-on-year Intensified competition and regulatory headwinds, especially in the U.S., impacting financial performance Operating loss reduced by 43% year-on-year, with no impairment expenses recognized in H1 2026 Continued cost discipline measures and lower headcount spend Strengthened capital structure and improved liquidity position Cash position of approx. USD 888 million as of June 30, 2026 2026 guidance: low-to-mid single-digit volume growth Polestar (NASDAQ:PSNY) presents its consolidated financial results and operational metrics for the three-month and six-month periods ended Ju

Albany Engineered Composites, a segment of Albany International Corp. (NYSE:AIN), announced today it reached an agreement with Boeing (NYSE:BA) to continue composite fuselage frame manufacturing for the 787 Dreamliner. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260903779626/en/Photo courtesy Boeing. A Boeing 787 in flight, enabled by advanced composite components from Albany Engineered Composites. Under the agreement, Albany continues to manufacture about 300 unique composite fuselage frames for the 787 Dreamliner, including forward sections 41 and 43 and aft section 47. Albany has produced composite fuselage frames for Sect

Vince Holding Corp., (NASDAQ:VNCE) ("VNCE" or the "Company"), a global retail platform, today announced that it plans to report its second quarter 2026 financial results pre-market on Thursday, September 10, 2026. The Company also plans to hold a conference call to discuss its financial results on the same day at 8:30 a.m. ET. During the conference call, the Company may answer questions concerning business and financial developments, trends and other business or financial matters. The Company's responses to these questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been previously disclosed. Those who wish to particip